Solid Tumor Cancer
Showing 26 - 50 of >10,000
Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica
Not yet recruiting
- Pathologically Confirmed Cancer Refractory to Conventional Therapy
- +7 more
- SNK02
-
Santa Monica, CaliforniaSarcoma Oncology Center
Aug 10, 2023
Advanced Pancreatic Cancer, Solid Tumor Malignancies Trial run by the (ProAgio)
Recruiting
- Advanced Pancreatic Cancer
- Solid Tumor Malignancies
-
Bethesda, MarylandNational Cancer Institute
Sep 26, 2022
Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)
Recruiting
- Cancer
- +11 more
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023
Advanced Solid Tumor Trial in Beijing (YK0901 cells)
Not yet recruiting
- Advanced Solid Tumor
- YK0901 cells
-
Beijing, ChinaDepartment of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023
Solid Tumor, Adult, Refractory Cancer Trial (GV20-0251)
Not yet recruiting
- Solid Tumor, Adult
- Refractory Cancer
- (no location specified)
Dec 21, 2022
Advanced Solid Tumor, Metastatic Solid Tumor Trial in Nashville, Dallas, Fairfax (JZP898, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
-
Nashville, Tennessee
- +2 more
Oct 26, 2023
Advanced Solid Tumor Trial in Guangzhou (YL201 for Injection)
Recruiting
- Advanced Solid Tumor
- YL201 for Injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 21, 2023
Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor Trial in Australia, France, United States (BGB-A3055, Tislelizumab)
Not yet recruiting
- Advanced Solid Tumor
- +2 more
-
Iowa City, Iowa
- +7 more
Jul 5, 2023
Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)
Recruiting
- Solid Tumor
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital
Jun 14, 2023
NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)
Not yet recruiting
- Non-Small Cell Lung Cancer
- +3 more
- HMBD-001
- +3 more
-
Sydney, New South Wales, AustraliaGenesisCare North Shore
Jun 16, 2023
Circulating Tumor Cells in Solid Tumors
Completed
- Solid Tumor, Adult
- Observational
-
Chapel Hill, North CarolinaRadiation Oncology Clinic - UNC Cancer Hospital
Sep 27, 2022
Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in
Not yet recruiting
- Head and Neck Cancer
- +8 more
- Tumor and HLA Profiling
- (no location specified)
Mar 31, 2023
Advanced Solid Tumor Trial in Boston (VAX014)
Not yet recruiting
- Advanced Solid Tumor
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 2, 2023
Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant
Completed
- Solid Tumor
- Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
- Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
- (no location specified)
Jun 8, 2023
Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)
Recruiting
- Breast Cancer
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Mar 13, 2023
Patients With Advanced Solid Tumors Trial in Beijing (TCC1727 tablet)
Not yet recruiting
- Patients With Advanced Solid Tumors
- TCC1727 tablet
-
Beijing, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Jul 23, 2023
s Recurrence and Response Via a Tumor Informed Assessment
Recruiting
- Cancer
- +4 more
- Personalized Cancer Monitoring (PCM)
-
San Francisco, California
- +1 more
Dec 5, 2022
Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- +7 more
- WM-A1-3389
- Pembrolizumab
-
Seoul, Seocho-gu, Korea, Republic of
- +1 more
May 14, 2023
Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)
Not yet recruiting
- Solid Tumor
- M1-c6v1
-
Kashiwa-shi, Chiba, Japan
- +2 more
Sep 19, 2023
Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an
Recruiting
- Metastatic Solid Tumor Cancer
- Dose escalation, first-in-human phase I clinical trial with an Expansion phase
-
Caen, France
- +2 more
Oct 11, 2022
Advanced Solid Tumor Trial in Beijing (CD73 Antigen)
Recruiting
- Advanced Solid Tumor
- CD73 Antigen
-
Beijing, ChinaBeijing Cancer Hospital
Jul 10, 2023
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)
Not yet recruiting
- Solid Tumor, Adult
- +2 more
- (no location specified)
May 3, 2023